Better then good...
I agree with magnum. this could fall way down with little resistance, since it looks like PP after PP Pharmagap's investors are losing confidence in them. and like me want out (for now).
Also, after all that has happened, i think GAP107b is going to need better then 'good' results on their trials to really get a move on.
Even a good drug is hard to market.